Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
UT MD Anderson Cancer Center
Welcome,
Profile
Billing
Logout
31 Products
13 Diseases
31 Products
34 Trials
1873 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
nelitolimod
(SD-101) / TriSalus Life Sci, UT MD Anderson Cancer Center
ASN007
/ Asana BioSci, Erasca, UT MD Anderson Cancer Center
ERAS-601
/ Erasca
RPM CD19-mbIL15-CAR-T cells
/ Alaunos Therap, UT MD Anderson Cancer Center, Eden BioCell
UCART123
/ Cellectis
KA2507
/ Karus Therap, UT MD Anderson Cancer Center
CAR.70/IL15-transduced CB-NK cells
/ UT MD Anderson Cancer Center
IACS-010759
/ UT MD Anderson Cancer Center
IPN60090
/ UT MD Anderson Cancer Center, Ipsen
JIN-001
/ J Ints Bio
NTRX-07
/ NeuroTherapia
OBX-115
/ Obsidian, UT MD Anderson Cancer Center
SY-104
/ Syena
TAK-007
/ Takeda, UT MD Anderson Cancer Center
UCART22
/ Cellectis
vibecotamab
(XmAb14045) / Xencor
BLU-222
/ Blueprint Medicines
CB-NK-TGF-βR2-/NR3C1
/ UT MD Anderson Cancer Center
CD33 CAR-T
/ Alaunos Therap, Precigen
CXCR2 and NGFR transduced TIL
/ UT MD Anderson Cancer Center
ION537
/ Ionis
MDA-TIL
/ Iovance Biotherap, UT MD Anderson Cancer Center
ROR1R-CAR-T Cells
/ UT MD Anderson Cancer Center
UCART CS1
/ Cellectis
Undisclosed MSC-derived Exosomes with KrasG12D siRNA
/ UT MD Anderson Cancer Center
attIL2-T
/ UT MD Anderson Cancer Center
mesenchymal stem cell- INFβ therapy
/ UT MD Anderson Cancer Center
